-
1
-
-
0035811625
-
Hepatitis C virus infection
-
Lauer G.M., Walker B.D. Hepatitis C virus infection. N Engl J Med 2001, 345:41-52.
-
(2001)
N Engl J Med
, vol.345
, pp. 41-52
-
-
Lauer, G.M.1
Walker, B.D.2
-
2
-
-
84856439885
-
Thyroid disorders in patients with chronic hepatitis C using interferon alpha and ribavirin therapy
-
Andrade L.J., Atta A.M., Atta M.L., Mangabeira C.N., Parana R. Thyroid disorders in patients with chronic hepatitis C using interferon alpha and ribavirin therapy. Braz J Infect Dis 2011, 15:377-381.
-
(2011)
Braz J Infect Dis
, vol.15
, pp. 377-381
-
-
Andrade, L.J.1
Atta, A.M.2
Atta, M.L.3
Mangabeira, C.N.4
Parana, R.5
-
3
-
-
84867516587
-
Thyroid dysfunction in Chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors
-
Yan Z., Fan K., Fan Y., et al. Thyroid dysfunction in Chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors. Hepat Mon 2012, 12:e6390.
-
(2012)
Hepat Mon
, vol.12
-
-
Yan, Z.1
Fan, K.2
Fan, Y.3
-
4
-
-
59249092117
-
Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C
-
Gelu-Simeon M., Burlaud A., Young J., Pelletier G., Buffet C. Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C. World J Gastroenterol 2009, 15:328-333.
-
(2009)
World J Gastroenterol
, vol.15
, pp. 328-333
-
-
Gelu-Simeon, M.1
Burlaud, A.2
Young, J.3
Pelletier, G.4
Buffet, C.5
-
5
-
-
41549098253
-
Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis
-
Rodríguez-Torres M., Ríos-Bedoya C.F., Ortiz-Lasanta G., Marxuach-Cuétara A.M., Jiménez-Rivera J. Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis. Ann Hepatol 2008, 7:72-77.
-
(2008)
Ann Hepatol
, vol.7
, pp. 72-77
-
-
Rodríguez-Torres, M.1
Ríos-Bedoya, C.F.2
Ortiz-Lasanta, G.3
Marxuach-Cuétara, A.M.4
Jiménez-Rivera, J.5
-
6
-
-
82855169549
-
Virus C genotype predisposes to primary hypothyroidism during interferon-alpha treatment for chronic hepatitis C
-
Pavan M.H., Pavin E.J., Gonçales F.L., Wittmann D.E. Virus C genotype predisposes to primary hypothyroidism during interferon-alpha treatment for chronic hepatitis C. Braz J Infect Dis 2011, 15:449-456.
-
(2011)
Braz J Infect Dis
, vol.15
, pp. 449-456
-
-
Pavan, M.H.1
Pavin, E.J.2
Gonçales, F.L.3
Wittmann, D.E.4
-
7
-
-
0026026353
-
Cardiotoxicity of interferon. A review of 44 cases
-
Sonnenblick M., Rosin A. Cardiotoxicity of interferon. A review of 44 cases. Chest 1991, 99:557-561.
-
(1991)
Chest
, vol.99
, pp. 557-561
-
-
Sonnenblick, M.1
Rosin, A.2
-
8
-
-
0030473452
-
Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C
-
Teragawa H., Hondo T., Amano H., Hino F., Ohbayashi M. Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C. Jpn Heart J 1996, 37:905-915.
-
(1996)
Jpn Heart J
, vol.37
, pp. 905-915
-
-
Teragawa, H.1
Hondo, T.2
Amano, H.3
Hino, F.4
Ohbayashi, M.5
-
9
-
-
79953171208
-
Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report
-
Popescu C., Arama V., Gliga S. Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report. BMC Gastroenterol 2011, 11:30.
-
(2011)
BMC Gastroenterol
, vol.11
, pp. 30
-
-
Popescu, C.1
Arama, V.2
Gliga, S.3
-
10
-
-
84866271740
-
Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma
-
Rauw J., Ahmed S., Petrella T. Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma. Med Oncol 2012, 29:1304-1307.
-
(2012)
Med Oncol
, vol.29
, pp. 1304-1307
-
-
Rauw, J.1
Ahmed, S.2
Petrella, T.3
-
11
-
-
0023685381
-
Recombinant alpha 2 interferon-related cardiomyopathy
-
Cohen M.C., Huberman M.S., Nesto R.W. Recombinant alpha 2 interferon-related cardiomyopathy. Am J Med 1988, 85:549-551.
-
(1988)
Am J Med
, vol.85
, pp. 549-551
-
-
Cohen, M.C.1
Huberman, M.S.2
Nesto, R.W.3
-
12
-
-
33644590228
-
Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C
-
Condat B., Asselah T., Zanditenas D., et al. Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C. Eur J Gastroenterol Hepatol 2006, 18:287-289.
-
(2006)
Eur J Gastroenterol Hepatol
, vol.18
, pp. 287-289
-
-
Condat, B.1
Asselah, T.2
Zanditenas, D.3
-
13
-
-
77950209150
-
Nonischemic cardiomyopathy related to pegylated interferon and ribavirin
-
Choy-Shan A., Berezovskaya S., Zinn A., Sedlis S.P., Bini E.J. Nonischemic cardiomyopathy related to pegylated interferon and ribavirin. Eur J Gastroenterol Hepatol 2009, 21:1438-1440.
-
(2009)
Eur J Gastroenterol Hepatol
, vol.21
, pp. 1438-1440
-
-
Choy-Shan, A.1
Berezovskaya, S.2
Zinn, A.3
Sedlis, S.P.4
Bini, E.J.5
-
14
-
-
0034619028
-
Adverse drugs reactions: definitions, diagnosis, and management
-
Edwards I.R., Aronson J.K. Adverse drugs reactions: definitions, diagnosis, and management. Lancet 2000, 356:1255-1259.
-
(2000)
Lancet
, vol.356
, pp. 1255-1259
-
-
Edwards, I.R.1
Aronson, J.K.2
-
15
-
-
84874023278
-
Is combination therapy for chronic hepatitis C toxic for cardiac functionα
-
Almawardy R., Elhammady W., Mousa N., Abotaleb Sh. Is combination therapy for chronic hepatitis C toxic for cardiac functionα. Hepat Mon 2012, 12:e6254.
-
(2012)
Hepat Mon
, vol.12
-
-
Almawardy, R.1
Elhammady, W.2
Mousa, N.3
Abotaleb, S.4
-
16
-
-
79953285607
-
Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease
-
Durante-Mangoni E., Iossa D., Pinto D., De Vincentiis L., Ragone E., Utili R. Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease. Dig Liver Dis 2011, 43:411-415.
-
(2011)
Dig Liver Dis
, vol.43
, pp. 411-415
-
-
Durante-Mangoni, E.1
Iossa, D.2
Pinto, D.3
De Vincentiis, L.4
Ragone, E.5
Utili, R.6
-
17
-
-
84866849352
-
Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010
-
Barut S., Gunal O., Erkorkmaz U., Yildiz F. Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010. Braz J Infect Dis 2012, 16:448-451.
-
(2012)
Braz J Infect Dis
, vol.16
, pp. 448-451
-
-
Barut, S.1
Gunal, O.2
Erkorkmaz, U.3
Yildiz, F.4
|